Miao Yufan, Zhang Luoya, Zhang Dongdong, Feng Mingming, Zhang Chunyang, Zhao Tong, Song Hanlu, Zhong Xiaoqin, Jiang Zhongyan, Li Longkang, Wei Xiaonuo, Li Wenjie, Li Xing
Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Eur J Nutr. 2024 Jun;63(4):1187-1201. doi: 10.1007/s00394-024-03345-7. Epub 2024 Feb 16.
The aim of this study was to evaluate the effects of vitamin D and/or calcium supplementation on sleep quality in individuals with prediabetes.
A 24-week randomized controlled trial (RCT) was conducted in a 212 Chinese population with prediabetes. Participants were randomly assigned to four groups: vitamin D + calcium group (1600 IU/day + 500 mg/day, n = 53), vitamin D group (1600 IU/day, n = 54), calcium group (500 mg/day, n = 51), and control group (placebo, n = 54). The Pittsburgh Sleep Quality Index (PSQI) was used as the primary outcome to assess sleep quality. Questionnaires and fasting blood samples were collected at baseline and post-intervention for demographic assessment and correlation index analysis.
After a 24-week intervention, a significant difference was observed in serum 25(OH)D concentration among the four groups (P < 0.05), and the total PSQI score in vitamin D + calcium group was lower compared to the preintervention levels. Subgroup analyses revealed improved sleep quality with calcium supplementation (P < 0.05) for specific groups, including women, individuals with a low baseline 25(OH)D level (< 30 ng/mL), and individuals in menopause. Moreover, correlation analysis revealed a negative correlation between the extent of change in sleep efficiency scores before and after the calcium intervention and the degree of change in insulin efficiency scores (r = - 0.264, P = 0.007), as well as the magnitude of change in islet beta cell function (r = - 0.304, P = 0.002).
The combined intervention of vitamin D and calcium, as well as calcium interventions alone, exhibits substantial potential for improving sleep quality in individuals with prediabetes.
The trial was registered in August 2019 as ChiCTR190002487.
本研究旨在评估补充维生素D和/或钙对糖尿病前期个体睡眠质量的影响。
对212名中国糖尿病前期人群进行了一项为期24周的随机对照试验(RCT)。参与者被随机分为四组:维生素D+钙组(1600国际单位/天+500毫克/天,n=53)、维生素D组(1600国际单位/天,n=54)、钙组(500毫克/天,n=51)和对照组(安慰剂,n=54)。匹兹堡睡眠质量指数(PSQI)用作评估睡眠质量的主要指标。在基线和干预后收集问卷和空腹血样,用于人口统计学评估和相关指标分析。
经过24周的干预,四组之间血清25(OH)D浓度存在显著差异(P<0.05),维生素D+钙组的PSQI总分低于干预前水平。亚组分析显示,特定人群(包括女性、基线25(OH)D水平低(<30纳克/毫升)的个体和绝经个体)补充钙后睡眠质量得到改善(P<0.05)。此外,相关性分析显示,钙干预前后睡眠效率得分的变化程度与胰岛素效率得分的变化程度之间存在负相关(r=-0.264,P=0.007),以及胰岛β细胞功能的变化幅度之间存在负相关(r=-0.304,P=0.002)。
维生素D和钙的联合干预以及单独的钙干预在改善糖尿病前期个体睡眠质量方面具有很大潜力。
该试验于2019年8月注册,注册号为ChiCTR190002487。